Manufacturer Halts Sales of Leukemia Drug Iclusig
Ariad Pharmaceuticals has suspended sales of the chemotherapy drug Iclusig (ponatinib), which is used to treat chronic myeloid leukemia (CML) and some forms of acute lymphocytic leukemia (ALL).
Experimental Drug Effective for Chronic Myeloid Leukemia
A small study of the experimental drug ponatanib has shown it is effective in treating chronic myeloid leukemia (CML) after other treatments have stopped working.
Experimental Technology Improves Cord Blood Transplants for Leukemia Patients
Researchers at the Fred Hutchinson Cancer Research Center have found a way to make umbilical cord blood transplants safer and more effective.